Uxin shares drop 45% as predicted by InvestingPro’s Fair Value model
OneMedNet Corp (EXCHANGE:ONMD) Director and Chief Medical Officer Jeffrey Yu reported purchasing shares of common stock in multiple transactions between February 1, 2024, and December 18, 2024. The total purchases amounted to $8,928, with prices ranging from $0.52 to $1.45. These purchases come as the stock, currently trading at $1.42, has shown significant volatility with a remarkable 245.5% return over the past six months, according to InvestingPro data.
Yu acquired a total of 9,350 shares through these transactions. The purchases were executed on various dates, with the largest single purchase occurring on February 1, 2024, for 1,357 shares at a weighted average price of $1.45.
On October 1, 2024, Yu also acquired 230,769 shares of common stock valued at $0.57 per share, totaling $131,538. These shares represent restricted stock units issued in lieu of cash compensation, which vested in full on July 1, 2025.The insider buying occurs as OneMedNet, with a market capitalization of $73.45 million, faces financial challenges. InvestingPro analysis indicates the company is currently overvalued relative to its Fair Value and maintains a weak financial health score, with short-term obligations exceeding liquid assets. Discover more insights and 10 additional ProTips with an InvestingPro subscription.
In other recent news, OneMedNet Corporation has expanded its real-world data network by approximately 22% since August 2025, adding about 380 provider sites to exceed a total of 2,130. The company’s iRWD network has grown significantly, with unique de-identified patient records increasing by 13 million to surpass 47 million. Clinical exams and images have expanded by 50 million, reaching more than 186 million. OneMedNet also announced a multi-year partnership with Palantir Technologies to enhance its healthcare data analytics platform. This collaboration will integrate Palantir’s Artificial Intelligence Platform with OneMedNet’s provider network. In addition, OneMedNet will showcase its AI-powered real-world data platform at ISPOR Europe, built on Palantir Technologies’ Foundry ecosystem. The company has regained compliance with Nasdaq’s minimum bid price requirement, maintaining a closing bid price of at least $1.00 per share for ten consecutive business days. These developments underscore OneMedNet’s commitment to advancing its data capabilities and maintaining its market presence.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.